Search research articles
Contact Us
Filters
Showing results (161-170 of 177) with videos related to
Page
of 18
Sort By:
Infection
|
July 7, 2014
Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT)
R Bruno, G Carosi, N Coppola, et al.
The Journal of Antimicrobial Chemotherapy
|
February 2, 2008
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon
D Aguilar Marucco, D Gonzalez de Requena, S Bonora, et al.
BMC Geriatrics
|
April 22, 2018
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years
G Guaraldi, A Malagoli, A Calcagno, et al.
Infection
|
May 28, 2009
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts
C Torti, G Lapadula, A Antinori, et al.
HIV Medicine
|
November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy
A Winston, W Stöhr, A Antinori, et al.
HIV Medicine
|
June 5, 2018
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study
E Focà, G Cavaglià, S Rusconi, et al.
Journal of Viral Hepatitis
|
January 25, 2007
A short course of pegylated interferon-alpha in acute HCV hepatitis
G Calleri, G Cariti, F Gaiottino, et al.
Infection
|
January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients
M M Santoro, A Bertoli, P Lorenzini, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2018
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV
A Borghetti, A Calcagno, F Lombardi, et al.
The Journal of Frailty & Aging
|
February 9, 2019
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons
G Guaraldi, S Marcotullio, R Maserati, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 177) with videos related to
Sort By:
Page
of 18
Infection
|
July 7, 2014
Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT)
R Bruno, G Carosi, N Coppola, et al.
The Journal of Antimicrobial Chemotherapy
|
February 2, 2008
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon
D Aguilar Marucco, D Gonzalez de Requena, S Bonora, et al.
BMC Geriatrics
|
April 22, 2018
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years
G Guaraldi, A Malagoli, A Calcagno, et al.
Infection
|
May 28, 2009
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts
C Torti, G Lapadula, A Antinori, et al.
HIV Medicine
|
November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy
A Winston, W Stöhr, A Antinori, et al.
HIV Medicine
|
June 5, 2018
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study
E Focà, G Cavaglià, S Rusconi, et al.
Journal of Viral Hepatitis
|
January 25, 2007
A short course of pegylated interferon-alpha in acute HCV hepatitis
G Calleri, G Cariti, F Gaiottino, et al.
Infection
|
January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients
M M Santoro, A Bertoli, P Lorenzini, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2018
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV
A Borghetti, A Calcagno, F Lombardi, et al.
The Journal of Frailty & Aging
|
February 9, 2019
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons
G Guaraldi, S Marcotullio, R Maserati, et al.
Page
of 18